1-(naphthalen-2-ylmethyl)-1H-benzo[d]imidazole | 305346-89-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 1-(naphthalen-2-ylmethyl)-1H-benzo[d]imidazole
• 英文别名: 1-(naphthalen-2-ylmethyl)benzimidazole
• CAS: 305346-89-8
• 化学式: C₁₈H₁₄N₂
• mdl: MFCD02074363
• 分子量: 258.323
• InChiKey: RBJWEJKVIMYELQ-UHFFFAOYSA-N

物化性质

• 沸点：
  482.7±38.0 °C(Predicted)
• 密度：
  1.15±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  20
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  17.8
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1-(naphthalen-2-ylmethyl)-1H-benzo[d]imidazole 、 6-氯乙酰基-2H-1,4-苯并恶嗪-3(4H)-酮 以 N,N-二甲基甲酰胺 为溶剂， 反应 8.0h， 以86%的产率得到1-(naphthalen-2-ylmethyl)-3-(6-acetyl-2H-1,4-benzoxazine-3(4H)-one)benzimidazolium chloride
  参考文献：
  名称：

  Coumarin or benzoxazinone based novel carbonic anhydrase inhibitors: synthesis, molecular docking and anticonvulsant studies

  摘要：

  Among many others, coumarin derivatives are known to show human carbonic anhydrase (hCA) inhibitory activity. Since hCA inhibition is one of the underlying mechanisms that account for the activities of some antiepileptic drugs (AEDs), hCA inhibitors are expected to have anti-seizure properties. There are also several studies reporting compounds with an imidazole and/or benzimidazole moiety which exert these pharmacological properties. In this study, we prepared fifteen novel coumarin-bearing imidazolium and benzimidazolium chloride, nine novel benzoxazinone-bearing imidazolium and benzimidazolium chloride derivatives and evaluated their hCA inhibitory activities and along with fourteen previously synthesized derivatives we scanned their anticonvulsant effects. As all compounds inhibited purified hCA isoforms I and II, some of them also proved protective against Maximal electroshock seizure (MES) and ScMet induced seizures in mice. Molecular docking studies with selected coumarin derivatives have revealed that these compounds bind to the active pocket of the enzyme in a similar fashion to that previously described for coumarin derivatives.

  DOI：

  10.3109/14756366.2015.1063624
• 作为产物：
  描述：

  甲醇 、 N-(naphthalen-2-ylmethyl)-2-nitroaniline 在 铁粉 、 氯化铵 作用下， 反应 48.0h， 以80%的产率得到1-(naphthalen-2-ylmethyl)-1H-benzo[d]imidazole
  参考文献：
  名称：

  甲醇作为 C1 源：硝基苯和醇的氧化还原偶联用于合成苯并咪唑

  摘要：

  我们提出了一种操作简单的氧化还原偶联，用于合成 N-1 取代的苯并咪唑，使用原料构建块 2-硝基苯胺衍生物作为前体，甲醇作为 C 1源。与使用二氨基苯和甲酸衍生物的常规合成相比，实现了更高的原子、步骤和氧化还原经济性以及出色的区域选择性。

  DOI：

  10.1039/d1gc03907e

文献信息

• Chiral N-heterocyclic carbene iridium catalyst for the enantioselective hydrosilane reduction of ketones
  作者：Yoshiki Manabe、Kanako Shinohara、Hanako Nakamura、Hiro Teramoto、Satoshi Sakaguchi

  DOI：10.1016/j.molcata.2016.05.020

  日期：2016.9

  NHC–Ag complex derived from N -(1-naphthalenylmethyl)-substituted benzimidazolium salt L12 , affording the corresponding alcohol in 92% yield and with 92% ee. Moreover, the evaluation of an Ir catalyst precursor showed that cationic [Ir(cod) 2 ]BF 4 complex could be used. Furthermore, the introduction of a chiral hydroxyamide side arm into the benzimidazolium salt was critical for the successful design of

  摘要 已开发了在室温下原位生成的 N-杂环卡宾 (NHC) Ir 配合物催化 (EtO) 2 MeSiH 对酮的对映选择性还原。在不对称氢化硅烷化反应中合成并筛选了一系列苯并咪唑盐。结果，[IrCl(cod)] 2 和 N-(1-萘基甲基)-取代的苯并咪唑盐 L12 衍生的 NHC-Ag 络合物的组合催化体系有效地还原苯丙酮，以 92% 的收率得到相应的醇，并且具有 92% 的 ee。此外，对Ir催化剂前体的评估表明可以使用阳离子[Ir(cod) 2 ]BF 4 络合物。此外，在苯并咪唑盐中引入手性羟基酰胺侧臂对于 NHC 配体的成功设计至关重要。
• Metal-Free Synthesis of Benzimidazoles via Oxidative Cyclization of <scp>d</scp>-Glucose with <i>o</i>-Phenylenediamines in Water
  作者：Dineshkumar Raja、Abigail Philips、Pushbaraj Palani、Wei-Yu Lin、Sundaramurthy Devikala、Gopal Chandru Senadi

  DOI：10.1021/acs.joc.0c01053

  日期：2020.9.4

  d-Glucose has been identified as an efficient C1 synthon in the synthesis of benzimidazoles from o-phenylenediamines via an oxidative cyclization strategy. Isotopic studies with 13C6-d-glucose and D2O unambiguously confirmed the source of methine. The notable features of this method include the following: broad functional group tolerance, a biorenewable methine source, excellent reaction yields, a

  d-葡萄糖已被确定为通过氧化环化策略由邻苯二胺合成苯并咪唑的有效C1合成子。用13 C 6 - d-葡萄糖和D 2 O进行的同位素研究明确证实了次甲基的来源。该方法的显着特征包括：宽泛的官能团耐受性，可生物再生的次甲基来源，优异的反应收率，较短的反应时间，水作为环境友好的溶剂以及以克为单位的维生素B 12组分的合成。
• Enantioselective catalytic hydrosilylation of propiophenone with a simple combination of a cationic iridium complex and a chiral azolium salt
  作者：Hiro Teramoto、Satoshi Sakaguchi

  DOI：10.1016/j.jorganchem.2018.09.001

  日期：2018.11

  investigation of the reaction progress as a function of time revealed that an iridium species, which was generated after 5 h of reaction time, catalyzed the stereoselective reduction with almost perfect facial selection of the ketone. An attempt to obtain a catalytic active species from the reaction of [Ir(cod)2]BF4 and chiral azolium salt has been made. The newly obtained iridium species promoted the

  这项研究旨在为使用催化量的[Ir（cod）2 ] BF 4和手性偶氮盐开发酮的对映选择性氢化硅烷化提供一个简单的程序。以前，催化不对称氢化硅烷化反应使用了定义明确的金属-N-杂环卡宾（NHC）配合物。所提出的方法具有避免制备NHC金属物质的重要优点。评价了一些反应参数，包括还原剂的量，溶剂，催化剂的负载量和配体结构。此外，对反应进程随时间变化的研究表明，在反应时间5小时后产生的铱物种催化了立体选择性还原反应，几乎完全选择了酮。已尝试从[Ir（cod）2 ] BF 4与手性偶氮盐的反应中获得催化活性物质。新获得的铱物质以高收率和对映选择性促进了酮的氢化硅烷化。
• Highly tunable anionic tethered N-heterocyclic carbene of Pd(II) complexes for asymmetric allylic alkylation reaction
  作者：Hiroshi Shirasaki、Miaki Kawakami、Haruka Yamada、Ryuichi Arakawa、Satoshi Sakaguchi

  DOI：10.1016/j.jorganchem.2012.12.015

  日期：2013.2

  combination of [Pd(allyl)Cl]2 and the azolium salt 9, containing a 3-pentyl group at N(3) position in the NHC ring, efficiently promoted the AAA reaction to afford the corresponding alkylated product 7 with 67% ee. Furthermore, it was found that the Pd/NHC ratio was an important factor; the AAA reaction with a Pd/NHC ratio of 1:1 took place smoothly, whereas utilization of a Pd/NHC ratio of 1:2 resulted

  研究了阴离子束缚的NHC配体体系在Pd催化的烯丙基不对称烷基化（AAA）反应中的多功能性。定义明确的阴离子酰胺化物/ NHC-Pd（II）络合物催化1,3-二苯基丙-3-烯-1-基乙酸酯（5）与NaCH（CO 2 Me）2的AAA反应。同样，通过使用原位生成的NHC-Pd（II）配合物发生AAA反应。各种NHC配体前体的筛选显示[Pd（烯丙基）Cl] 2和重氮盐9的组合有效地促进了AAA反应，该重氮盐9在NHC环的N（3）位置含有一个3-戊基。得到相应的烷基化产物7拥有67％的ee。另外，发现Pd / NHC比是重要的因素。Pd / NHC比为1：1的AAA反应顺利进行，而Pd / NHC比为1：2的利用可能导致底物的转化率较低，这可能是由于形成了催化惰性的bis（NHC）–Pd （二）情结。事实上，一项独立的实验表明，双（NHC）-Pd（II）络合物是通过用两当量的NHC-Ag络合物处理[Pd（烯丙基）Cl]
• Anti-tumor activity of lipophilic imidazolium salts on select NSCLC cell lines
  作者：Brian D. Wright、Michael C. Deblock、Patrick O. Wagers、Ernest Duah、Nikki K. Robishaw、Kerri L. Shelton、Marie R. Southerland、Michael A. DeBord、Kortney M. Kersten、Lucas J. McDonald、Jason A. Stiel、Matthew J. Panzner、Claire A. Tessier、Sailaja Paruchuri、Wiley J. Youngs

  DOI：10.1007/s00044-015-1330-z

  日期：2015.7

  The anti-tumor activity of imidazolium salts is highly dependent upon the substituents on the nitrogen atoms of the imidazolium cation. We have synthesized and characterized a series of naphthalene-substituted imidazolium salts and tested them against a variety of non-small-cell lung cancer cell lines. Several of these complexes displayed anticancer activity comparable to cisplatin. These compounds induced apoptosis in the NCI-H460 cell line as determined by Annexin V staining, caspase-3, and PARP cleavage. These results strongly suggest that this class of compounds can serve as potent chemotherapeutic agents.